К основному контенту

European stocks rally ahead of COVID vaccine approval

European stocks rally ahead of COVID vaccine approval

(Reuters) - European stocks rally on Tuesday as optimism over coronavirus vaccines boost hopes for economic recovery and fueling stock markets to extend November rally.

Having declined the day before due to profit-taking by investors at the end of the month, the pan-European STOXX 600 index by 12:05 Moscow time rose 0.85%. In November, the benchmark added almost 14%.

German DAX up 1.03%, French CAC up 0.99%.

Strong economic data from China also supported the optimism. A private survey found that business activity in the country's manufacturing sector accelerated growth in November at the fastest pace in 10 years.

(Susan Matthew in Bangalore, translated by Olga Devyatiarova. Editor Anna Kozlova)

Комментарии

Отправить комментарий

Популярные сообщения из этого блога

US stocks decline, but Dow Jones may see maximum monthly gain in 33 years

US stocks decline , but Dow Jones may see maximum monthly gain in 33 years American stock indices are showing a downward trend. Meanwhile, the Dow for November may show the best monthly result in 1987 amid optimism over news about COVID-19 vaccines and the prospect of new stimulus measures. The indicator is up almost 12.9% since the beginning of the month as of the close of the trading session on Friday.
1 комментарий
Далее...

Wall Street is down, vaccine in focus

Wall Street is down, vaccine in focus Investing.com - US equities open broadly lower on Monday, trailing after sharp gains in November. By 09:35 am ET (2:35 pm GMT), the Dow Jones Industrial Average fell 181 points, or 0.6%, to 29,730. S&The P 500 also fell 0.2% while the NASDAQ Composite rose 0.2%.. Slack (NYSE: WORK) shares hit another all-time high amid news last week of a possible merger with Salesforce (NYSE: CRM).
1 комментарий
Далее...

Gazprom discusses the sale of part of Gazprom Neft shares to the market

"Gazprom" discusses the sale of part of the shares "Gazprom Neft" to the market "Gazprom (MCX: GAZP)" discusses the possibility of selling shares "Gazprom Neft" on the market, CFO said "Gazprom Neft" Alexey Yankevich during the dialogue with investors organized by "VTB (MCX: VTBR) My investments". "I would like to "Gazprom Neft (MCX: SIBN)" entered the indices, but this requires 10% free float, now it has "Gazprom Neft" more than 5%.
Отправить комментарий
Далее...